Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.
Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology. The company develops a protein engineering platform designed for multispecific therapies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 14, 2021 | Series A | $50M | 2 | Versant Ventures Samsara BioCapital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Versant Ventures | Yes | Series A |
Samsara BioCapital | Yes | Series A |